Healthy men test generic vs. brand drug in fasting study
NCT ID NCT03050164
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a generic gefitinib tablet works the same as the brand-name version (Iressa) in the body. It involved 38 healthy Chinese men who took a single dose of each under fasting conditions. The goal was to check if the two drugs are bioequivalent, meaning they produce similar drug levels in the blood. This was not a treatment study for any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALENCE STUDY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.